000 01613 a2200505 4500
005 20250516122445.0
264 0 _c20131104
008 201311s 0 0 eng d
022 _a1873-7064
024 7 _a10.1016/j.neuropharm.2012.10.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLodge, Nicholas J
245 0 0 _aPharmacological and behavioral characterization of the novel CRF1 antagonist BMS-763534.
_h[electronic resource]
260 _bNeuropharmacology
_cApr 2013
300 _a284-93 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAminopyridines
_xchemistry
650 0 4 _aAnimals
650 0 4 _aCell Line, Tumor
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMotor Activity
_xdrug effects
650 0 4 _aProtein Binding
_xphysiology
650 0 4 _aPyrazines
_xchemistry
650 0 4 _aRats
650 0 4 _aRats, Inbred SHR
650 0 4 _aReceptors, Corticotropin-Releasing Hormone
_xantagonists & inhibitors
650 0 4 _aSheep
650 0 4 _aSwine
650 0 4 _aCRF Receptor, Type 1
700 1 _aLelas, Snjezana
700 1 _aLi, Yu-Wen
700 1 _aMolski, Thaddeus
700 1 _aGrace, James
700 1 _aSivarao, Digavalli V
700 1 _aPost-Munson, Debra
700 1 _aHealy, Francine
700 1 _aBronson, Joanne J
700 1 _aHartz, Richard
700 1 _aMacor, John E
700 1 _aZaczek, Robert
773 0 _tNeuropharmacology
_gvol. 67
_gp. 284-93
856 4 0 _uhttps://doi.org/10.1016/j.neuropharm.2012.10.025
_zAvailable from publisher's website
999 _c22284891
_d22284891